Abstract B116: Optimizing a CD71-targeting Probody drug conjugate (PDC) for activity in multiple solid tumor and lymphoma models and for tolerability in nonhuman primatesShweta Singh, Michael Kavanaugh, Niharika Chauhan et al.|Molecular Cancer Therapeutics|2018Cited by 5